-+ 0.00%
-+ 0.00%
-+ 0.00%

Autonomix Medical attends EuroPCR with abstracts on pancreatic cancer pain mitigation

PUBT·05/18/2026 12:45:22
Listen to the news
Autonomix Medical attends EuroPCR with abstracts on pancreatic cancer pain mitigation
  • Autonomix Medical will attend EuroPCR 2026 in Paris on May 19-22, 2026.
  • Two accepted presentations will highlight long-term data on pancreatic cancer pain mitigation using its transvascular nerve-targeting platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605180845PRIMZONEFULLFEED9721857) on May 18, 2026, and is solely responsible for the information contained therein.